How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

Esther Joan Moulthrop Muench Plonk died July 31, 2026, at The Neighborhoods, a nursing home in Columbia, Mo., after a long battle with Alzheimer’s and vascular dementia. She was born July 2, 1940, in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed. The above button links to ...

Esther Joan Moulthrop Muench Plonk died July 31, 2026, in Columbia, Mo., after a long battle with Alzheimer’s. She was born July 2, 1940, in Kansas City, Mo., the daughter of Roscoe Emmett Moulthrop ...

Performs recursive feature elimination to find optimal feature subset. Tracks performance at each step and identifies best configuration.

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

For more details about the Plonky2 argument system, see this writeup. If you find a security issue in the codebase, please refer to our Security guidelines for private disclosure. While Plonky2 is ...